Global Health Innovative Technology Fund (GHIT)

Japan’s first public-private partnership to advance the development of new health technologies for the developing world.

Global Health Innovative Technology Fund (GHIT)

The Global Health Innovative Technology Fund (GHIT) is the world's first public-private partnership (PPP) in which a consortium of private companies have come together to work with government and the civil sector to facilitate and fund global health technology discovery and development through global partnerships. The GHIT Fund is a partnership between the Government of Japan, a consortium of Japanese pharmaceutical companies (in alphabetical order: Astellas Pharma Inc.; Daiichi Sankyo Company Ltd.; Eisai Co., Ltd.; Shionogi & Co., Ltd.; Takeda), the Bill & Melinda Gates Foundation, to advance the research and development of new medicines, vaccines and diagnostics to fight infectious diseases in the developing world. The GHIT Fund aims to reinforce Japan’s contribution to global health by developing new health technologies, utilizing the highly developed science and technology capacity found at the country’s pharmaceutical companies, universities and research institutions. In providing grants for promising research, the GHIT Fund will help bridge the gap between basic research and clinical studies, allowing for unprecedented medicines, vaccines and diagnostics.


  • The Global Fund to Fight AIDS, Tuberculosis and Malaria (GFATM)

    Switzerland | Staff size: 501-1000

    The Global Fund is a 21st-century partnership organization designed to accelerate the end of AIDS, tuberculosis and malaria as epidemics.

    Founded in 2002, the Global Fund is a...

  • Astellas Pharma

    Service Providers
    Japan | Staff size: 10,000+

    Astellas Pharma Inc. is a Japanese pharmaceutical company which aims to become an R&D-driven global pharmaceutical company contributing to people's health. The Astellas Group’s...

  • Daiichi Sankyo

    Service Providers
    Japan | Staff size: 10,000+

    Daiichi Sankyo is a global pharmaceutical company engaged in the research and development, manufacturing, and sale and marketing of innovative and generic drugs, vaccines, and over-the counter...

  • Eisai

    Service Providers
    Japan | Staff size: 10,000+

    Eisai Co., Ltd. is a Japan-based company mainly engaged in the manufacturing and sale of pharmaceutical products. The Company operates in two business segments. The Pharmaceutical segment is...

  • Shionogi

    Service Providers
    Japan | Staff size: Unknown

    Shionogi was founded in 1878 in Osaka, Japan where our headquarters remain. The company has grown to become a major research-driven pharmaceutical company dedicated to placing the highest value...

  • Takeda

    Service Providers
    Japan | Staff size: 5001-10,000

    For more than 230 years, Takeda has been serving society with innovative medicines, helping patients reclaim valuable moments of life from illness. Now, with new healthcare solutions from...

More Resources

Key Information

  • Start Date 2013